Carlos S Moreno
Overview
Explore the profile of Carlos S Moreno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
3427
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Camargo A, Remoli B, Portela L, Fioretto M, Chuffa L, Moreno C, et al.
Mol Cell Endocrinol
. 2021 Jul;
535:111393.
PMID: 34245846
Reproductive cancers in both genders represent serious health problems, whose incidence has significantly risen over the past decades. Although considerable differences among reproductive cancers exist, we aimed to identify similar...
12.
Guo S, Huang S, Jiang X, Hu H, Han D, Moreno C, et al.
BMC Genomics
. 2021 Apr;
22(1):286.
PMID: 33879051
Background: Analysis of lymphocyte cell lines revealed substantial differences in the expression of mRNA and microRNA (miRNA) among human populations. The extent of such population-associated differences in actual human tissues...
13.
Li Z, Jella K, Jaafar L, Moreno C, Dynan W
Life Sci Space Res (Amst)
. 2021 Feb;
28:11-17.
PMID: 33612174
Exosomes are extracellular vesicles that mediate transport of nucleic acids, proteins, and other molecules. Prior work has implicated exosomes in the transmission of radiation nontargeted effects. Here we investigate the...
14.
Phan N, Moreno C, Lai Y
Cytotechnology
. 2020 Jul;
72(4):603.
PMID: 32715403
An amendment to this paper has been published and can be accessed via the original article.
15.
Koyen A, Madden M, Park D, Minten E, Kapoor-Vazirani P, Werner E, et al.
Oncogene
. 2020 May;
39(25):4798-4813.
PMID: 32457468
Small cell lung cancer (SCLC) is a highly aggressive malignancy with poor outcomes associated with resistance to cisplatin-based chemotherapy. Enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of...
16.
Phan N, Moreno C, Lai Y
Cytotechnology
. 2020 May;
72(4):527-537.
PMID: 32419068
The present study aims to investigate the association between SOX4, Wnt signaling, and miRNAs under Wnt3 induction via bioinformatics analysis and functional essays. To briefly explore the expression of SOX4...
17.
Cinar B, Al-Mathkour M, Khan S, Moreno C
J Biol Chem
. 2020 May;
295(25):8550-8559.
PMID: 32376689
The transcriptional coactivator YAP1 (yes-associated protein 1) regulates cell proliferation, cell-cell interactions, organ size, and tumorigenesis. Post-transcriptional modifications and nuclear translocation of YAP1 are crucial for its nuclear activity. The...
18.
Buchwald Z, Tian S, Rossi M, Smith G, Switchenko J, Hauenstein J, et al.
Sci Rep
. 2020 May;
10(1):7355.
PMID: 32355162
Allele-specific copy number analysis of tumors (ASCAT) assesses copy number variations (CNV) while accounting for aberrant cell fraction and tumor ploidy. We evaluated if ASCAT-assessed CNV are associated with survival...
19.
Li Z, Sun C, Tao S, Osunkoya A, Arnold R, Petros J, et al.
Transl Oncol
. 2020 Mar;
13(4):100751.
PMID: 32199273
In our previous study, we observed that androgen deprivation therapy (ADT) may induce a compensatory increase in MAPK or JNK signaling. Here, we tested the effects of the MEK inhibitors...
20.
Ogden A, Bhattarai S, Sahoo B, Mongan N, Alsaleem M, Green A, et al.
Sci Rep
. 2020 Feb;
10(1):3009.
PMID: 32080212
Epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 3 (HER3) have been investigated as triple-negative breast cancer (TNBC) biomarkers. Reduced EGFR levels can be compensated by increases...